0001209191-14-021388.txt : 20140318
0001209191-14-021388.hdr.sgml : 20140318
20140318160522
ACCESSION NUMBER: 0001209191-14-021388
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140314
FILED AS OF DATE: 20140318
DATE AS OF CHANGE: 20140318
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: QUESTCOR PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000891288
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 330476164
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1300 NORTH KELLOGG DRIVE
STREET 2: SUITE D
CITY: ANAHEIM
STATE: CA
ZIP: 92807
BUSINESS PHONE: 714-786-4200
MAIL ADDRESS:
STREET 1: 1300 NORTH KELLOGG DRIVE
STREET 2: SUITE D
CITY: ANAHEIM
STATE: CA
ZIP: 92807
FORMER COMPANY:
FORMER CONFORMED NAME: CYPROS PHARMACEUTICAL CORP
DATE OF NAME CHANGE: 19930328
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Young David
CENTRAL INDEX KEY: 0001378166
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14758
FILM NUMBER: 14700972
MAIL ADDRESS:
STREET 1: 8850 STANFORD BOULEVARD
STREET 2: SUITE 2500
CITY: COLUMBIA
STATE: MD
ZIP: 21045
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2014-03-14
0
0000891288
QUESTCOR PHARMACEUTICALS INC
QCOR
0001378166
Young David
1300 NORTH KELLOGG DRIVE
SUITE D
ANAHEIM
CA
92807
0
1
0
0
Chief Scientific Officer
Common Stock
2014-03-14
4
M
0
6000
4.54
A
117741
D
Common Stock
2014-03-14
4
S
0
2587
61.7841
D
115154
D
Common Stock
2014-03-14
4
S
0
3413
62.6526
D
111741
D
Stock Option (right to buy)
4.54
2014-03-14
4
M
0
6000
0.00
D
2019-10-29
Common Stock
6000
77000
D
Non-qualified stock options granted under the Questcor Pharmaceuticals, Inc. 2006 Equity Incentive Award Plan on 10/30/2009.
The option was granted on 10/30/2009 for the right to buy 350,000 shares of common stock of the Issuer. The option provided for monthly vesting over 48 months from the date of grant with a twelve month cliff, whereby no options vested until after the twelfth month from the date of grant.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.47 -$62.46 and $62.50 - $62.85, respectively. The reporting person undertakes to provide Questcor Pharmaceuticals, Inc., any security holder of Questcor Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4.
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan (the "Automatic Trading Plan") adopted by the reporting person in the fourth quarter of 2013 and effective 30 days post-adoption. There have been no changes to the Automatic Trading Plan since its adoption, and there have been no sales by the Reporting Person outside of the Automatic Trading Plan since its adoption. The Automatic Trading Plan controls the exact dates and amounts of sales.
/s/ David Young
2014-03-18